Healthcare provider profile · identity verified

Michael J. Lynch, D.O.

Family Practice · ORLAND PARK, IL · NPI 1619915873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	606	181
Levothyroxine Sodium	Levothyroxine Sodium	534	147
Losartan Potassium	Losartan Potassium	492	139
Pantoprazole Sodium	Pantoprazole Sodium	483	157
Amlodipine Besylate	Amlodipine Besylate	410	116
Prednisone	Prednisone	350	247
Metformin Hcl	Metformin Hcl	304	85
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	293	84
Lisinopril	Lisinopril	275	83
Diclofenac Sodium	Diclofenac Sodium	245	100
Alprazolam	Alprazolam	228	84
Escitalopram Oxalate	Escitalopram Oxalate	214	60
Pravastatin Sodium	Pravastatin Sodium	209	55
Rosuvastatin Calcium	Rosuvastatin Calcium	201	67
Simvastatin	Simvastatin	191	54
Metoprolol Succinate	Metoprolol Succinate	187	55
Gabapentin	Gabapentin	169	47
Glipizide	Glipizide	169	46
Allopurinol	Allopurinol	164	43
Tamsulosin Hcl	Tamsulosin Hcl	164	44
Omeprazole	Omeprazole	159	53
Azithromycin	Azithromycin	154	112
Zolpidem Tartrate	Zolpidem Tartrate	137	40
Tramadol Hcl	Tramadol Hcl	136	62
Furosemide	Furosemide	135	52
Hydrochlorothiazide	Hydrochlorothiazide	119	38
Tizanidine Hcl	Tizanidine Hcl	119	61
Meloxicam	Meloxicam	117	35
Cephalexin	Cephalexin	112	97
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	107	83
Albuterol Sulfate Hfa	Albuterol Sulfate	103	40
Carvedilol	Carvedilol	102	28
Fluticasone Propionate	Fluticasone Propionate	100	32
Sertraline Hcl	Sertraline Hcl	95	23
Hydrocortisone	Hydrocortisone	92	51
Metoprolol Tartrate	Metoprolol Tartrate	91	26
Alendronate Sodium	Alendronate Sodium	90	11
Eliquis	Apixaban	85	26
Synthroid	Levothyroxine Sodium	85	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	32
Doxycycline Hyclate	Doxycycline Hyclate	76	56
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	76	59
Propranolol Hcl Er	Propranolol Hcl	76	suppressed
Potassium Chloride	Potassium Chloride	75	26
Montelukast Sodium	Montelukast Sodium	74	19
Lovastatin	Lovastatin	72	20
Clonidine Hcl	Clonidine Hcl	71	16
Trazodone Hcl	Trazodone Hcl	71	19
Celecoxib	Celecoxib	70	26
Levetiracetam	Levetiracetam	69	suppressed
Donepezil Hcl	Donepezil Hcl	67	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	18
Myrbetriq	Mirabegron	62	suppressed
Ozempic	Semaglutide	61	12
Pioglitazone Hcl	Pioglitazone Hcl	60	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	14
Verapamil Er	Verapamil Hcl	56	15
Methylprednisolone	Methylprednisolone	53	43
Metformin Hcl Er	Metformin Hcl	48	15
Azelastine Hcl	Azelastine Hcl	46	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	12
Diltiazem 24hr Er	Diltiazem Hcl	44	11
Famotidine	Famotidine	44	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	11
Glipizide Er	Glipizide	43	16
Meclizine Hcl	Meclizine Hcl	43	24
Pregabalin	Pregabalin	43	suppressed
Ondansetron Hcl	Ondansetron Hcl	40	18
Cefdinir	Cefdinir	39	36
Duloxetine Hcl	Duloxetine Hcl	38	11
Atenolol	Atenolol	37	11
Clonazepam	Clonazepam	36	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	36	14
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	34	24
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	11
Bupropion Xl	Bupropion Hcl	32	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	21
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	23
Naproxen	Naproxen	27	17
Ezetimibe	Ezetimibe	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Risedronate Sodium	Risedronate Sodium	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	23	22
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Glyburide	Glyburide	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	11
Digoxin	Digoxin	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Temazepam	Temazepam	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Torsemide	Torsemide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cefuroxime	Cefuroxime Axetil	17	15
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Procto-Med Hc	Hydrocortisone	17	suppressed
Tiadylt Er	Diltiazem Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Diazepam	Diazepam	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Amoxicillin	Amoxicillin	15	12
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Linzess	Linaclotide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Trandolapril	Trandolapril	14	suppressed
Valsartan	Valsartan	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nystatin	Nystatin	13	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Trandolapril-Verapamil Er	Trandolapril/Verapamil Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Baclofen	Baclofen	12	suppressed
Metronidazole	Metronidazole	12	11
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error